My Companies
Notification
Account
Noumed renewed a three-year OTC medicines supply agreement with a major Australian pharmacy network, covering an expanded portfolio and projected AUD30 million (approximately ₹204 crore) of orders. The contract is international, non-related-party, and provides meaningful revenue visibility.
Sai Parenterals Renews AUD 30 Million Australian OTC Supply Agreement
Sai Parenterals Redirects ₹83.83 Crore IPO Proceeds To Saicriti Acquisition
Sai Parenterals Approves ₹101.86 Crore IPO Proceeds Shift Into Two Pharma Acquisitions
Sai Parenterals Subsidiary Bags AUD 202 Million OTC Supply Deal